Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
Clinical trial NCT05148546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05148546
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2025-04-22
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.